The lawsuits do not mean the drug has been recalled or deemed unsafe by regulators
As part of our commitment to supporting people living with obesity in their weight management journey, we are introducing a new option with the Zepbound KwikPen, a device trusted by patients globally and in the United States for other Lilly medicines. In 2025, over 1 million patients accessed Lilly treatments through LillyDirect, 4 which offers self-pay pricing at a 50% or greater discount compared to the list price of other incretin (GLP-1) medicines for obesity
Nausea, changes in appetite, and mild gastrointestinal effects are common initially and may feel amplified by travel stress, unfamiliar foods, or dehydration
When your doctor asks why you want a GLP-1, you should be able to explain that these medications address the neurohormonal pathways that regulate appetite and energy balance
If you are on all three medications, monitoring INR more frequently when starting tirzepatide is prudent
Alternative GLP-1 Protocols When Semaglutide Plateaus Persist If semaglutide alone reaches a stubborn plateau despite dose optimization, PlexusDx offers compounded alternatives that work through different mechanisms